Meissner says the production of single-use systems has begun from its newly-established site in County Mayo, Ireland. The filtration firm announced in February 2019 plans to establish a production site in Castlebar, Ireland to support demand for its single-use products form the biopharma industry. Sixteen months on and the facility has begun supplying the space after a 10,000 square-foot ISO class 7 cleanroom was completed in mid-April. With the current COVID-19 crisis still ongoing, there was no ribbon-cutting ceremony. “This…
Friday, May 29, 2020 Daily Archives
Oxford Biomedica to make AstraZeneca’s coronavirus vaccine for trials
Oxford Biomedica will make trial supplies of AZD1222 – AstraZeneca’s SARS-CoV-2 candidate vaccine – under a deal agreed this week. The cell and gene therapy contractor will make the adenovirus vector-based vaccine at its recently established manufacturing facility – known as Oxbox – at the Oxford Science Park in Oxford, UK. The agreement – which is for one year – will see Oxford Biomedica supply AstraZeneca with multiple batches of vaccine, the majority of which are expected to be produced…